The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

UCLA, Los Angeles

Benefactor: The Eli and Edythe Broad Foundation

$20 million

Science: UCLA researchers are making demonstrable inroads against melanoma. With a series of CIRM grants, they've progressed from basic research and are poised to embark on clinical trials to treat the deadly form of skin cancer.

- Last updated October 04 2012 06:20 PM ET
Join the Conversation
Bad to the bone: A medical horror story

When medical device company Synthes decided to illegally test a bone cement on people, the results were disastrous. A disturbing tale of corporate crime and punishment.

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.